TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Total AssetsTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Total AssetsAnnual figures by period end, from SEC filings.2008-12-31: $32.92B2009-12-31: $33.21B2010-12-31: $38.15B2011-12-31: $50.14B2012-12-31: $50.61B2013-12-31: $47.51B2017-12-31: $70.61B2018-12-31: $60.68B2019-12-31: $57.47B2020-12-31: $50.64B2021-12-31: $47.67B2022-06-30: $45.93B2022-09-30: $44.25B2022-12-31: $44.01B2023-03-31: $43.46B2023-06-30: $43.10B2023-09-30: $42.09B2023-12-31: $43.48B2024-12-31: $39.33B2025-12-31: $40.75B$40.75B2008-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$40.75B+3.6%2026-02-03Balance as of period end2024-12-31$39.33B-9.6%2026-02-03Balance as of period end2023-12-31$43.48B—2025-02-05Balance as of period end2023-09-30$42.09B—2024-02-12Balance as of period end2023-06-30$43.10B—2024-02-12Balance as of period end2023-03-31$43.46B—2024-02-12Balance as of period end2022-12-31$44.01B—2024-02-12Balance as of period end2022-09-30$44.25B—2024-02-12Balance as of period end2022-06-30$45.93B—2024-02-12Balance as of period end2021-12-31$47.67B-5.9%2023-02-10Balance as of period end2020-12-31$50.64B-11.9%2022-02-09Balance as of period end2019-12-31$57.47B-5.3%2021-02-10Balance as of period end2018-12-31$60.68B-14.1%2020-02-21Balance as of period end2017-12-31$70.61B—2019-02-19Balance as of period end2013-12-31$47.51B-6.1%2014-02-10Balance as of period end2012-12-31$50.61B+0.9%2014-02-10Balance as of period end2011-12-31$50.14B+31.4%2013-02-12Balance as of period end2010-12-31$38.15B+14.9%2012-02-17Balance as of period end2009-12-31$33.21B+0.9%2011-02-15Balance as of period end2008-12-31$32.92B—2010-02-22Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)